Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,930.00
(
-0.09%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
90.68
(
-2.14%
)
Bitcoin
75,733.04
(
2.53%
)
News Focus
News Focus
Post# of 822115
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4173
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: dstock07734 post# 559731

Sunday, 01/15/2023 10:46:14 PM

Sunday, January 15, 2023 10:46:14 PM

Post# of 822115
FDA provides guidance and post hoc trial data is not considered approvable by them. That provides pretty strong evidence of how they will respond to NWBO's post hoc protocol, endpoints, external comparator and SAP when it is included in a application for commercial approval.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News